CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-01 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise | +2,250 | 59,596 | ||
| 2020-03-01 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −662 | $20.84 | $14K | 58,934 |
| 2020-03-01 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −2,250 | 0 | ||
| 2020-03-01 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Option exercise | +4,500 | 71,168 | ||
| 2020-03-01 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Shares withheld for taxes | −1,323 | $20.84 | $28K | 69,845 |
| 2020-03-01 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Option exercise · Restricted Stock Unit Award | −4,500 | 0 | ||
| 2020-03-01 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Option exercise | +2,250 | 39,243 | ||
| 2020-03-01 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Shares withheld for taxes | −662 | $20.84 | $14K | 38,581 |
| 2020-03-01 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Option exercise · Restricted Stock Unit Award | −2,250 | 0 | ||
| 2020-02-24 | Wysenski Nancy Director | Purchase | +6,940 | $19.65 | $136K | 11,242 |
| 2020-02-21 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +6,875 | 15,955 | ||
| 2020-02-21 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −6,875 | 20,625 |
Page 75 of 75 · 1,492 trades